Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. Within this case, we report a 57-year-old cystic fibrosis patient with chronic kidney disease (CKD) St...
Saved in:
Main Authors: | Tyler Miller (Author), Cristina Pastuch (Author), Lisa Garavaglia (Author), Kelley Gannon (Author), Anthony Parravani (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience of the use of tobramycin for inhalation in children with cystic fibrosis
by: A. V. Orlov, et al.
Published: (2012) -
Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation
by: Timothy P. Gauthier, et al.
Published: (2015) -
Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report
by: Anbar Ran D, et al.
Published: (2007) -
Long-term safety and efficacy of tobramycin in the management of cystic fibrosis
by: Vázquez-Espinosa E, et al.
Published: (2015) -
Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis
by: Jérémy Reverchon, et al.
Published: (2022)